Many groups have demonstrated that targeting the intronic splicing silencer N1 (ISS-N1) downstream of exon 7 with ASOs can efficiently promote exon 7 inclusion, which increases the production of full-length SMN protein and significantly extends the survival of SMA mice [9,10]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.